1. Home
  2. OLMA vs DCGO Comparison

OLMA vs DCGO Comparison

Compare OLMA & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • DCGO
  • Stock Information
  • Founded
  • OLMA 2006
  • DCGO 2015
  • Country
  • OLMA United States
  • DCGO United States
  • Employees
  • OLMA N/A
  • DCGO N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • DCGO Managed Health Care
  • Sector
  • OLMA Health Care
  • DCGO Health Care
  • Exchange
  • OLMA Nasdaq
  • DCGO Nasdaq
  • Market Cap
  • OLMA 289.0M
  • DCGO 272.3M
  • IPO Year
  • OLMA 2020
  • DCGO N/A
  • Fundamental
  • Price
  • OLMA $4.11
  • DCGO $2.64
  • Analyst Decision
  • OLMA Strong Buy
  • DCGO Strong Buy
  • Analyst Count
  • OLMA 4
  • DCGO 5
  • Target Price
  • OLMA $26.75
  • DCGO $5.30
  • AVG Volume (30 Days)
  • OLMA 939.3K
  • DCGO 985.6K
  • Earning Date
  • OLMA 03-18-2025
  • DCGO 05-07-2025
  • Dividend Yield
  • OLMA N/A
  • DCGO N/A
  • EPS Growth
  • OLMA N/A
  • DCGO 200.00
  • EPS
  • OLMA N/A
  • DCGO 0.18
  • Revenue
  • OLMA N/A
  • DCGO $616,555,132.00
  • Revenue This Year
  • OLMA N/A
  • DCGO N/A
  • Revenue Next Year
  • OLMA N/A
  • DCGO $7.65
  • P/E Ratio
  • OLMA N/A
  • DCGO $14.75
  • Revenue Growth
  • OLMA N/A
  • DCGO N/A
  • 52 Week Low
  • OLMA $3.93
  • DCGO $2.63
  • 52 Week High
  • OLMA $16.62
  • DCGO $5.68
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 37.74
  • DCGO 28.36
  • Support Level
  • OLMA $3.93
  • DCGO $2.63
  • Resistance Level
  • OLMA $4.45
  • DCGO $2.86
  • Average True Range (ATR)
  • OLMA 0.31
  • DCGO 0.14
  • MACD
  • OLMA 0.04
  • DCGO 0.05
  • Stochastic Oscillator
  • OLMA 21.95
  • DCGO 2.22

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Share on Social Networks: